- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03639727
Cough in Eastern and Central Finland
February 11, 2019 updated by: Heikki Koskela, Kuopio University Hospital
Comparison of citric acid and mannitol cough provocation tests among subjects with chronic cough and healthy volunteers.
Study Overview
Status
Completed
Conditions
Detailed Description
35 subjects with chronic cough plus 25 subjects without any cough will be asked to participate.
The study consists of two visits in the outpatient clinic of Kuopio University Hospital, department of respiratory medicine, 2 - 7 days apart.
They will fill in the Leicester Cough Questionnaire and undergo two different cough provocation tests, in random order: Mannitol test and citric acid test.
If a chest x-ray has not been taken within 6 months, it will be taken.
Study Type
Interventional
Enrollment (Actual)
61
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Kuopio, Finland, 70029
- Kuopio University Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria, Chronic cough patients:
(both criteria must be fulfilled)
- presence of current chronic cough (> 8 weeks)
- Leicester Cough Questionnaire total score < 17
Inclusion criteria, healthy volunteers
- absence of any form of cough
Exclusion Criteria:
- age < 18 years
- any disability which would challenge the subject's ability to understand the purpose and methods of the study
- pregnancy
- breastfeeding
- current smoking or ex smoking more than 10 pack years
- any thoracic x-ray finding indicating urgent mediacal interventions
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Citric acid aerosol bronchial challenge
Inhaled citric acid aerosol.
This study investigates the diagnostic accuracy of two cough provocation tests, one of which is citric acid aerosol challenge.
|
Inhalation challenge by citric acid aerosol to investigate the subject's cough sensitivity
|
Active Comparator: Mannitol aerosol bronchial challenge
Inhaled mannitol aerosol.
This study investigates the diagnostic accuracy of two cough provocation tests, one of which is mannitol aerosol challenge.
|
Inhalation challenge by mannitol aerosol to investigate the subject's cough sensitivity
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Receiver operator characteristic curves of the citric acid and the mannitol aerosol bronchial challenges
Time Frame: Within one week from the start of the study in each individual
|
Receiver operator characteristic curve describes the ability of the bronchial challenge to separate the cough patients from healthy volunteers
|
Within one week from the start of the study in each individual
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Leicester Cough Questionnaire total score
Time Frame: The first study day
|
Measures cough-spesific quality of life.
Range is 3 - 21 with low total score indicating poor cough-spesific quality of life.
The three Leicester Cough Questionnaire subscales are added together to form the total score.
|
The first study day
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Heikki O Koskela, MD, Kuopio University Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 1, 2018
Primary Completion (Actual)
December 31, 2018
Study Completion (Actual)
January 31, 2019
Study Registration Dates
First Submitted
August 9, 2018
First Submitted That Met QC Criteria
August 18, 2018
First Posted (Actual)
August 21, 2018
Study Record Updates
Last Update Posted (Actual)
February 12, 2019
Last Update Submitted That Met QC Criteria
February 11, 2019
Last Verified
February 1, 2019
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Respiratory Tract Diseases
- Respiration Disorders
- Signs and Symptoms, Respiratory
- Cough
- Physiological Effects of Drugs
- Molecular Mechanisms of Pharmacological Action
- Natriuretic Agents
- Diuretics, Osmotic
- Diuretics
- Anticoagulants
- Chelating Agents
- Sequestering Agents
- Calcium Chelating Agents
- Mannitol
- Citric Acid
- Sodium Citrate
Other Study ID Numbers
- KUH5801136
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Cough
-
Trevi TherapeuticsRecruitingRefractory Chronic CoughCanada, United Kingdom
-
Mayo ClinicRecruitingRefractory Chronic CoughUnited States
-
Guangzhou Medical UniversityNingbo SensCure Biotechnology Co., Ltd.Recruiting
-
Stuart MazzoneMelbourne Health; Merck Sharp & Dohme LLC; Monash UniversityNot yet recruitingChronic CoughAustralia
-
ShionogiCompletedChronic CoughUnited States, United Kingdom, Japan, Ukraine, Poland, Czechia
-
Respivant Sciences GmbHRespivant Sciences Inc.TerminatedChronic Cough | IPF | Persistent Cough in IPFUnited States, United Kingdom, Netherlands, Australia, Belgium, New Zealand, Turkey, Italy, Germany, Czechia, Canada
-
Genentech, Inc.RecruitingChronic Refractory Cough (CRC) With Non-atopic Asthma | CRC With Atopic Asthma | Unexplained Chronic Cough | CRC With Chronic Obstructive Pulmonary Disease | CRC With Chronic Obstructive Pulmonary Disease With Chronic BronchitisUnited States, Australia, United Kingdom, Canada
-
Merck Sharp & Dohme LLCCompletedChronic CoughCanada, Czechia, Denmark, Hungary, Peru, Poland, Ukraine, United Kingdom, United States, Australia, China, Colombia, Germany, Guatemala, Israel, Italy, Malaysia, New Zealand, South Africa, Turkey
-
Hull University Teaching Hospitals NHS TrustRecruitingChronic CoughUnited Kingdom
Clinical Trials on Citric acid aerosol bronchial challenge
-
Guy's and St Thomas' NHS Foundation TrustKing's College LondonRecruiting
-
University of East AngliaUniversity of Manchester; Asthma UK Centre for Applied ResearchCompleted
-
Lithuanian University of Health SciencesUniversity of Groningen; Research Council of LithuaniaCompleted
-
Lithuanian University of Health SciencesRecruitingAllergic Asthma | Severe Eosinophilic AsthmaLithuania
-
University Hospital, Strasbourg, FranceTerminated
-
Johann Wolfgang Goethe University HospitalCompletedHouse Dust Mite Allergy | Bronchial HyperresponsivenessGermany
-
University Medical Center GroningenChiesi Farmaceutici S.p.A.Completed
-
Infante, Javier Molina, M.D.UnknownColonoscopy | Bowel CleansingSpain
-
Lundquist Institute for Biomedical Innovation at...Completed
-
Seoul National University Bundang HospitalCompleted